Andrew Murphy

Insider Reports History

Entity
Individual
Location
Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY
Signature
/s/ Andrew Murphy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Murphy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. EVP Research Common Stock 49.1K $35.9M $730.81 Dec 16, 2024 Direct
REGENERON PHARMACEUTICALS, INC. EVP Research Common Stock 4.33K $3.16M $730.81 Dec 16, 2024 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. EVP Research Non-Qualified Stock Option (right to buy) 20K Mar 13, 2024 Direct
REGENERON PHARMACEUTICALS, INC. EVP Research Non-Qualified Stock Option (right to buy) 13.5K Dec 6, 2024 Direct

Insider Reports Filed by Andrew Murphy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Dec 16, 2024 1 -$770K 4 Dec 18, 2024 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Dec 6, 2024 3 -$387K 4 Dec 10, 2024 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Nov 8, 2024 1 $0 4 Nov 12, 2024 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Aug 13, 2024 21 -$14.9M 4 Aug 15, 2024 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Mar 13, 2024 17 -$11.4M 4 Mar 15, 2024 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Dec 12, 2023 1 -$6.56M 4 Dec 14, 2023 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2023 5 -$5.62M 4 Dec 12, 2023 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Dec 4, 2023 15 -$10.9M 4 Dec 6, 2023 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Nov 13, 2023 14 -$10.5M 4 Nov 15, 2023 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. May 9, 2023 1 $0 4 May 10, 2023 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Dec 16, 2022 2 $0 4 Dec 20, 2022 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Dec 9, 2022 1 -$371K 4 Dec 13, 2022 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Nov 14, 2022 24 -$5.6M 4 Nov 16, 2022 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Aug 15, 2022 14 -$4.59M 4 Aug 17, 2022 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. May 16, 2022 18 -$4.75M 4 May 18, 2022 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Feb 14, 2022 14 -$4.49M 4 Feb 16, 2022 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Dec 11, 2021 1 -$463K 4 Dec 14, 2021 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2021 21 -$10M 4 Dec 10, 2021 EVP Research
REGN REGENERON PHARMACEUTICALS, INC. Nov 15, 2021 21 -$9.81M 4 Nov 17, 2021 EVP Research